Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease
Status:
Completed
Trial end date:
2019-08-28
Target enrollment:
Participant gender:
Summary
This study focuses on the evaluation of low doses (600 and 1200 mg) and short treatment
duration (at 3, 7 and 10 days) of fexinidazole (Fexi) to determine the minimal efficacious
and safe dose for the treatment of adult patients with chronic indeterminate Chagas Disease
(CD).